Yüklüyor......
Platelet-lymphocyte ratio acts as an indicator of poor prognosis in patients with breast cancer
Platelet-lymphocyte ratio (PLR) is a hematological parameter which is investigated as a biomarker for prognosis in patients with breast cancer. Due to the controversial results from previous studies, we performed a meta-analysis. Databases of PubMed, Embase and Web of Science were searched to identi...
Kaydedildi:
| Yayımlandı: | Oncotarget |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Impact Journals LLC
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5352031/ https://ncbi.nlm.nih.gov/pubmed/27906679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13714 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|